6,029 New First Dose Vaccinations, Cumulative Nears 3.7 Million... 412 Additional Adverse Reactions Reported (Update)

635 New COVID-19 Cases Added on the 12th... 613 Local Infections

[Image source=Yonhap News]

[Asia Economy Reporter Kim Ji-hee] On the 12th, the number of new domestic COVID-19 cases recorded 635. As the holiday effect disappeared, the number surged by 124 compared to the previous day, rising back to the 600 range.

The Central Disease Control Headquarters (CDCH) announced that as of midnight on that day, the number of new domestic COVID-19 cases increased by 635, bringing the total to 128,918. In terms of infection routes, 613 were locally transmitted cases, and 22 were imported cases. On that day, the number of suspected case tests was 37,255, with 32,448 tests conducted at temporary screening clinics in the metropolitan area and 8,795 tests at temporary screening clinics outside the metropolitan area. A total of 120 confirmed cases were detected at the temporary screening clinics, with 101 in the metropolitan area and 19 outside the metropolitan area.

By region, many confirmed cases were reported in the metropolitan area: 220 in Seoul, 184 in Gyeonggi, and 20 in Incheon. Outside the metropolitan area, confirmed cases were reported in all regions, including 31 in Ulsan, 22 each in Gwangju and Jeonbuk, 17 in Jeonnam, 16 in Gangwon, 15 in Gyeongnam, 13 in Jeju, 12 in Chungbuk, 10 in Chungnam, 8 in Daejeon, 7 in Gyeongbuk, 5 in Daegu, and 1 in Sejong.

The cumulative number of COVID-19 deaths increased by 5 from the previous day, reaching 1,884. The number of critically ill patients decreased by 4 to 167. An additional 656 patients were declared recovered and released from isolation, bringing the total to 119,373.

Additionally, the COVID-19 Vaccination Response Promotion Team reported that as of midnight on that day, 6,029 new first-dose vaccinations were administered, bringing the total number of people who completed the first dose to 3,698,657. AstraZeneca vaccine recipients numbered 2,027,084, and Pfizer vaccine recipients numbered 1,671,573. An additional 80,788 second-dose vaccinations were administered, bringing the total to 664,813. The vaccination rate relative to the population was 7.2% for the first dose and 1.3% for completed vaccinations.

The number of reported suspected adverse reactions following COVID-19 vaccination increased by 412 from the previous day, totaling 20,678. Newly reported adverse reactions included 36 major adverse reaction cases and 1 death. The remainder were mild symptoms such as muscle pain and headache.

This content was produced with the assistance of AI translation services.